Do you know that developing a single drug could cross over $2.6 billion over a period that usually lasts for over 10 years (1)?
The design and manufacturing of drugs is a lengthy and costly process. However, Big data and advanced analytics can change the rules.
From accelerating drug discovery and development to increasing the efficacy of clinical trials, McKinsey’s research reveals that the impact of advanced analytics in the pharma industry range as high as 15 to 30 percent of EBITDA over five years.
However, there are significant challenges that need to be addressed before pharma businesses can begin to realize advantages with pharmaceutical data analytics.
One of them is technological. Many pharma companies are saddled with legacy systems containing heterogeneous and disparate data. Indeed, increasing the ability to share data requires rationalizing and connecting these systems.
That is why it is crucial to discuss the importance of having the right data platform for pharmaceutical companies to enable data access, governance, delivery, and security.
On July 13, at 4:00 PM CET, Matthias Falk, Manager for Cloud and DevOps Engineering at Unt8 with years of experience leading several cloud and data platform projects in the Pharma industry will tell you everything to start or scale your platform.
Who should be concerned?
• Infrastructure / IT
• Quality departments
• Data people